
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol.
Sec. Radiation Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1503188
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: This study aimed to develop and validate an Informer-Convolutional Neural Network (CNN) model to predict the gamma passing rate (GPR) for patient-specific quality assurance in volumetric modulated arc therapy (VMAT), enhancing treatment safety and efficacy by integrating multiple data sources. Methods: Analyzing 465 VMAT treatment plans covering head & neck, chest, and abdomen, the study extracted data from 31 complexity indicators, 123 radiomics features, and 123 dosimetrics indices, along with daily linac performance data including 141 key performance indicators. A hybrid Informer-CNN architecture was used to handle both temporal and non-temporal data for predicting GPR. Results: The Informer-CNN model demonstrated superior predictive performance over traditional models like Convolutional Neural Networks (CNN), Long Short-Term Memory(LSTM), and Informer.Specifically, in the validation set, the model achieved a mean absolute error (MAE) of 0.0273 and a root mean square error (RMSE) of 0.0360 using the 3%/3mm criterion. In the test set, the MAE was 0.0327 and the RMSE was 0.0468.The model also showed high classification performance with AUC scores of 0.97 and 0.95 in test and validation sets, respectively.The developed Informer-CNN model significantly enhances the prediction accuracy and classification of gamma passing rates in VMAT treatment plans. It facilitates early integration of daily accelerator performance data, improving the assessment and verification of treatment plans for better patient-specific quality assurance.
Keywords: AI-Enhanced Cancer Radiotherapy Quality Assessment: Utilizing Daily Linac Performance, Radiomics, dosimetrics, and Planning Complexity learning, Radiotherapy, patient-specific quality assurance, Prediction model, Gamma passing rate
Received: 01 Oct 2024; Accepted: 21 Feb 2025.
Copyright: © 2025 Deng, Zhao, Huang, Zhang, Hong and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yaolin Zhao, School of Nuclear Science and Technology, Xi'an Jiaotong University, Xi'an, Shanxi, China
Dengdian Huang, School of Artificial Intelligence, Optics and Electronics (iOPEN), Northwestern Polytechnical University, Xi'an, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.